BRIEF-Arcturus Therapeutics Acquires Exclusive License To Mrna Manufacturing Technology From Alexion Pharmaceuticals

路透社 · Feb 22, 2021 22:14

Feb 22 (Reuters) - Arcturus Therapeutics Holdings Inc :
* ARCTURUS THERAPEUTICS ACQUIRES EXCLUSIVE LICENSE TO MRNA MANUFACTURING TECHNOLOGY FROM ALEXION PHARMACEUTICALS

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

BRIEF-Arcturus Therapeutics Acquires Exclusive License To Mrna Manufacturing Technology From Alexion Pharmaceuticals

Risk Disclaimer